Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.59 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.54 |
| ▸ | CPA1 | P15085 | 2/20 | 0.54 |
| ▸ | CPB1 | P15086 | 1/20 | 0.54 |
| ▸ | CPA3 | P15088 | 1/20 | 0.54 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.47 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.47 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.47 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.47 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3,3-Diphenylpropanoic Acid SCHEMBL5283373 | 1.00 | GABBR2 (0.59) | GABBR2GABBR1FFAR1CPA1CPB1 | |
| 3,3-Diphenylpropanoic Acid SCHEMBL5740483 | 0.97 | GABBR2 (0.57) | GABBR2GABBR1FFAR1CPA1CPB1 | |
| 3,3-Diphenylpropanoic Acid SCHEMBL28079188 | 0.97 | GABBR2 (0.57) | GABBR2GABBR1FFAR1CPA1CPB1 | |
| 3,3-Diphenylpropanoic Acid SCHEMBL28079326 | 0.97 | GABBR2 (0.57) | GABBR2GABBR1FFAR1CPA1CPB1 | |
| 3,3-Diphenylpropanoic Acid SCHEMBL9100138 | 0.97 | GABBR2 (0.57) | GABBR2GABBR1FFAR1CPA1CPB1 | |
| SCHEMBL3658988 | 0.89 | CNR1 (0.51) | GABBR2GABBR1FFAR1CPA1CPB1 | |
| 3,3-Diphenylpropanoic Acid SCHEMBL20981393 | 0.89 | FFAR1 (0.59) | GABBR2GABBR1FFAR1CPA1CPB1 | |
| SCHEMBL5499422 | 0.89 | FFAR1 (0.59) | GABBR2GABBR1FFAR1LMNA | |
| SCHEMBL9155517 | 0.87 | CACNA2D1 (0.55) | GABBR2GABBR1FFAR1CYP2C19LMNA | |
| SCHEMBL170301 | 0.87 | SLC6A2 (0.55) | GABBR2GABBR1FFAR1CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| CN-111465699-B | Method for producing amines from carbonyl compounds by transaminase reaction under salt precipitation | 恩齐米克斯公司 | 2024-09-20 | — | — | CN | claimed |
| EP-4429704-A1 | IONIC LIQUID COMPOSITIONS | I2O Therapeutics, Inc. (US) | 2024-09-18 | — | — | EP | claimed |
| US-12018303-B2 | Method for preparing amines from carbonyl compounds by transaminase reaction under salt precipitation | ENZYMICALS AG (DE) | 2024-06-25 | — | — | US | claimed |
| CN-117683336-B | Bamboo charcoal biodegradable conductive composite material and preparation method thereof | 国际竹藤中心 | 2024-04-23 | — | — | CN | claimed |
| CN-117683336-A | Bamboo charcoal biodegradable conductive composite material and preparation method thereof | 国际竹藤中心 | 2024-03-12 | — | — | CN | claimed |
| CN-116514628-A | Synthesis method of 1-methyl-3-phenylindene | 南京神奇科技开发有限公司 | 2023-08-01 | — | — | CN | claimed |
| WO-2023086499-A1 | IONIC LIQUID COMPOSITIONS | I2O THERAPEUTICS, INC. (US) | 2023-05-19 | — | — | WO | claimed |
| CN-114904739-B | Water-based fireproof coating for steel structure and preparation method thereof | 广东百安环保新材料有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-115282120-A | Schiff base supermolecule assembled nano-particles and application thereof as delivery carrier | 山东大学 | 2022-11-04 | — | — | CN | claimed |
| EP-1044184-A1 | SYNTHESIS OF 3-ARYL-1-INDANAMINES | Pharm-Eco Laboratoires, Incorporated (US) | 2000-10-18 | — | — | EP | claimed |
| CN-1264274-A | Herbicidal compositions of tetrazolinone herbicides and antidotes therefor | ZENECA LTD (GB) | 2000-08-23 | — | — | CN | claimed |
| EP-1004590-A2 | Glucidic esters of branched carboxylic acids capable of inducing erythroid cellular differentiation | ASSOCIAZIONE VENETA PER LA LOTTA ALLA TALASSEMIA (IT) | 2000-05-31 | — | — | EP | claimed |
| EP-0999748-A1 | HERBICIDAL COMPOSITIONS OF TETRAZOLINONE HERBICIDES AND ANTIDOTES THEREFOR | ZENECA LIMITED (GB) | 2000-05-17 | — | — | EP | claimed |
| EP-0994707-A1 | INHIBITORS OF NAALADASE ENZYME ACTIVITY | GUILFORD PHARMACEUTICALS INC. (US) | 2000-04-26 | — | — | EP | claimed |
| WO-1999035119-A1 | SYNTHESIS OF 3-ARYL-1-INDANAMINES | PHARM-ECO LABORATORIES, INC. (US) | 1999-07-15 | — | — | WO | claimed |
| WO-1999007413-A1 | SUBSTANCE P INHIBITORS IN COMBINATION WITH NMDA-BLOCKERS FOR TREATING PAIN | ALGOS PHARMACEUTICAL CORPORATION (US) | 1999-02-18 | — | — | WO | claimed |
| WO-1999003348-A1 | HERBICIDAL COMPOSITIONS OF TETRAZOLINONE HERBICIDES AND ANTIDOTES THEREFOR | ZENECA LIMITED (GB) | 1999-01-28 | — | — | WO | claimed |
| WO-1998053812-A1 | INHIBITORS OF NAALADASE ENZYME ACTIVITY | GUILFORD PHARMACEUTICALS INC. (US) | 1998-12-03 | — | — | WO | claimed |
| US-3953494-A | FORMING ACIDS AND ESTERS | SOUTHERN ILLINOIS UNIVERSITY FOUNDATION (US) | 1976-04-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018303-B2 | Method for preparing amines from carbonyl compounds by transaminase reaction under salt precipitation | GOT1, GOT2, OAT | GABBR2 1339/4885GABBR1 1427/4885FFAR1 3429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.